Desmutagenic effects of N-acetylcysteine on direct and indirect mutagens.
D015073:2-Acetylaminofluorene / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000633:toxicity; D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D000873:Anthracenes / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000633:toxicity; D001386:Azides / Q000037:antagonists & inhibitors / Q000633:toxicity; D001564:Benzo(a)pyrene / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000633:toxicity; D001711:Biotransformation; D004305:Dose-Response Relationship, Drug; D005449:Fluorenes / Q000037:antagonists & inhibitors / Q000633:toxicity; D008769:Methylnitronitrosoguanidine / Q000037:antagonists & inhibitors / Q000633:toxicity; D008862:Microsomes, Liver / Q000378:metabolism; D009152:Mutagenicity Tests; D009153:Mutagens; D051381:Rats; D012486:Salmonella typhimurium / Q000235:genetics*; D019810:Sodium Azide
D000873:Anthracenes; D001386:Azides; D005449:Fluorenes; D009153:Mutagens; D008769:Methylnitronitrosoguanidine; C019499:2-nitrofluorene; D001564:Benzo(a)pyrene; C006593:2-anthramine; D019810:Sodium Azide; D015073:2-Acetylaminofluorene; D000111:Acetylcysteine